To this end, we conducted a comparative analysis of plasma Hsp90α levels and cognitive performance scores (assessed using the MoCA, DST, VFT, TMTA, TMTB, AVLT-IR, AVLT-DR, and LMT) between T2DM patients with and without MCI. This evidence concerns the gene HSP90AA1 and type 2 diabetes mellitus.